戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 geting the vasculature, GSCs, and GECs, using drugs already approved by the FDA, can reduce both tumor size and invasiven
2  cyclic lipopeptide, is the only membrane-active antibiotic approved by the U.S. Food and Drug Administration so far.
3                        A number of injectable hydrogels are approved by FDA as surgery sealants, tissue adhesives, and ar
4 golimod) is recognized as an immunosuppressant and has been approved by the Food and Drug Administration to treat refract
5   To date, over 100 small-molecule oncology drugs have been approved by the FDA.
6 selective androgen receptor modulators, which have not been approved by the US Food and Drug Administration (FDA), to enh
7                                         Drugs and biologics approved by the FDA that mention TPPs are associated with mor
8   A companion diagnostic is a test for a specific biomarker-approved by the United States Food and Drug Administration-qu
9 tions and indications for active pharmaceutical ingredients approved by FDA and other regulatory agencies.
10 e comparative therapeutic value of all new cancer medicines approved by the US Food and Drug Administration (FDA) and the
11 fibrillator (ICD) that was "non-MRI-conditional" (i.e., not approved by the Food and Drug Administration for MRI scanning
12 tively from February 2012 through July 2015 under protocols approved by the local animal studies committee and institutio
13 rapy with an HSV vector expressing GM-CSF has been recently approved by the Food and Drug Administration for the treatmen
14 quency of postmarket safety events among novel therapeutics approved by the US Food and Drug Administration (FDA), and to
15 ospective interpretation of prospectively acquired data was approved by the local ethics committee.
16                    Left atrial appendage closure (LAAC) was approved by the U.S. Food and Drug Administration (FDA) as a
17               Materials and Methods The animal protocol was approved by the institutional animal care and use committee a
18 cts provided written informed consent, and the protocol was approved by the university institutional review board.
19 rgeted oligonucleotide-based drug (nusinersen/Spinraza) was approved by US Food and Drug Administration (FDA) in late 201
20                         Materials and Methods The study was approved by a research ethics committee, and participants gav
21                         Materials and Methods The study was approved by institutional animal and human studies committees
22                        Materials and Methods This study was approved by the animal care committee.
23            Materials and Methods This prospective study was approved by the ethics review board, and informed consent was
24                         Materials and Methods The study was approved by the GE Global Research Center Institutional Anima
25            Materials and Methods This prospective study was approved by the Institutional Animal Care and Use Committee.
26          Materials and Methods This retrospective study was approved by the institutional board review; written informed
27 als and Methods This single-center, retrospective study was approved by the institutional review board and compliant with
28                        Materials and Methods This study was approved by the institutional review board and compliant with
29                        Materials and Methods This study was approved by the institutional review board, and all participa
30                        Materials and Methods This study was approved by the institutional review board, and written infor
31          Materials and Methods This retrospective study was approved by the institutional review board.
32                         Materials and Methods The study was approved by the institutional review board.
33                        Materials and Methods This study was approved by the institutional review board.
34        Materials and Methods This HIPAA-compliant study was approved by the institutional review board.
35 ls and Methods This HIPAA-compliant retrospective study was approved by the institutional review board; the requirement t
36 terials and Methods This prospective case-control study was approved by the local ethics committee and the research depar
37                         Materials and Methods The study was approved by the local Ethics Committee, and all patients or t
38                         Materials and Methods The study was approved by the local ethics committee.
39            Materials and Methods This prospective study was approved by the local ethics committees, and written informed
40           Materials and Methods This case-control study was approved by the local research ethics committee.
41                         Materials and Methods The study was approved by the local review board (NL42888.029.13).
42        Materials and Methods This HIPAA-compliant study was approved by the regional ethics committee.
43 ts from a prospective cohort study were included, which was approved by the local ethics board and written informed conse
44                  Materials and Methods All experiments were approved by the institutional animal care and use committee.
45 ug/ml and disk diffusion (30/20-mug disk) test methods were approved by the CLSI Subcommittee on Antimicrobial Susceptibi
46                            Romidepsin and pralatrexate were approved by the US Food and Drug Administration for patients
47                   Materials and Methods The procedures were approved by the institutional animal care committee.
48                        Materials and Methods Protocols were approved by the office of biologic safety and institutional a
49 1358 individuals had died and had brain autopsies that were approved by board-certified neuropathologists.
50                                For oncology drugs that were approved by the US Food and Drug Administration (FDA) and req

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。